SG11202101920WA - Composition for eradicating helicobacter pylori - Google Patents

Composition for eradicating helicobacter pylori

Info

Publication number
SG11202101920WA
SG11202101920WA SG11202101920WA SG11202101920WA SG11202101920WA SG 11202101920W A SG11202101920W A SG 11202101920WA SG 11202101920W A SG11202101920W A SG 11202101920WA SG 11202101920W A SG11202101920W A SG 11202101920WA SG 11202101920W A SG11202101920W A SG 11202101920WA
Authority
SG
Singapore
Prior art keywords
composition
helicobacter pylori
eradicating helicobacter
eradicating
pylori
Prior art date
Application number
SG11202101920WA
Other languages
English (en)
Inventor
Bong Tae Kim
Dongkyu Kim
Eun Ji Kim
Ji Won Lee
Kyeongmin Oh
Ahrong Kim
Geun Seog Song
Shin-Young Ryu
Eun Kyung Kim
Naree Shin
Hyun Ji Kang
Jae Min Kim
Yu-Gyeong Park
Haneul Jeong
Original Assignee
Hk Inno N Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hk Inno N Corp filed Critical Hk Inno N Corp
Publication of SG11202101920WA publication Critical patent/SG11202101920WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11202101920WA 2018-08-29 2019-08-28 Composition for eradicating helicobacter pylori SG11202101920WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180102250 2018-08-29
PCT/KR2019/011017 WO2020045992A1 (en) 2018-08-29 2019-08-28 Composition for eradicating helicobacter pylori

Publications (1)

Publication Number Publication Date
SG11202101920WA true SG11202101920WA (en) 2021-04-29

Family

ID=69643254

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202101920WA SG11202101920WA (en) 2018-08-29 2019-08-28 Composition for eradicating helicobacter pylori

Country Status (19)

Country Link
US (1) US20210196685A1 (ja)
EP (1) EP3843723A4 (ja)
JP (1) JP7189327B2 (ja)
KR (1) KR20200026118A (ja)
CN (1) CN112638378A (ja)
AR (1) AR116026A1 (ja)
AU (1) AU2019328903B2 (ja)
BR (1) BR112021003578A2 (ja)
CA (1) CA3107624C (ja)
EA (1) EA202190622A1 (ja)
GE (1) GEP20227431B (ja)
JO (1) JOP20190201A1 (ja)
MX (1) MX2021002278A (ja)
MY (1) MY195494A (ja)
PH (1) PH12021550385A1 (ja)
SG (1) SG11202101920WA (ja)
UA (1) UA126993C2 (ja)
UY (1) UY38348A (ja)
WO (1) WO2020045992A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190043437A (ko) 2017-10-18 2019-04-26 씨제이헬스케어 주식회사 단백질 키나제 억제제로서의 헤테로고리 화합물
WO2020210878A1 (en) * 2019-04-18 2020-10-22 Borody Thomas J Compositions and methods for treating, ameliorating and preventing h. pylori infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753324B2 (en) * 1998-07-15 2004-06-22 Hassan Jomaa Phosphorous organic compounds and their use
WO2007072146A1 (en) 2005-12-19 2007-06-28 Pfizer Japan Inc. Chromane substituted benzimidazoles and their use as acid pump inhibitors
CN101015694A (zh) * 2006-02-07 2007-08-15 沈阳东宇药业有限公司 一种治疗幽门螺旋杆菌感染的复方口服制剂
EP3305291B1 (en) * 2015-06-08 2021-05-19 HK inno.N Corporation Uses of benzimidazole derivative for nocturnal acid breakthrough
WO2017125912A1 (en) * 2016-01-21 2017-07-27 Dexcel Pharma Technologies Ltd. Methods for treating helicobacter infection
KR101829706B1 (ko) * 2016-09-21 2018-02-19 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 산부가염
CN108379258B (zh) * 2017-11-30 2020-02-18 中国医学科学院医药生物技术研究所 瑞香素在抗幽门螺杆菌中的应用

Also Published As

Publication number Publication date
MX2021002278A (es) 2021-08-11
KR20200026118A (ko) 2020-03-10
AR116026A1 (es) 2021-03-25
US20210196685A1 (en) 2021-07-01
UA126993C2 (uk) 2023-03-01
AU2019328903A8 (en) 2021-05-27
EP3843723A4 (en) 2022-06-29
WO2020045992A1 (en) 2020-03-05
JP7189327B2 (ja) 2022-12-13
BR112021003578A2 (pt) 2021-05-18
CA3107624C (en) 2023-10-03
GEP20227431B (en) 2022-10-25
UY38348A (es) 2020-03-31
CA3107624A1 (en) 2020-03-05
CN112638378A (zh) 2021-04-09
AU2019328903A1 (en) 2021-04-29
AU2019328903B2 (en) 2023-01-05
PH12021550385A1 (en) 2021-09-20
JOP20190201A1 (ar) 2020-02-29
JP2021535910A (ja) 2021-12-23
EP3843723A1 (en) 2021-07-07
EA202190622A1 (ru) 2021-06-10
MY195494A (en) 2023-01-26

Similar Documents

Publication Publication Date Title
GB201811312D0 (en) Compositions
GB2586745B (en) Compositions
PL3634444T3 (pl) Kompozycje do zastosowania w leczeniu Helicobacter pylori
SG11202009259VA (en) Compositions
GB2575549B (en) Chocolate composition
SG11202104306XA (en) Compositions
GB201811100D0 (en) Composition
ZA202204622B (en) Polypeptide and polypeptide composition for inhibiting and eliminating biofilm formed by helicobacter pylori
ZA202100515B (en) Curcuminoid compositions
EP3658590C0 (de) Photoinitiatoren für lichthärtende zusammensetzungen
ZA202006762B (en) Improved wetting composition
GB201812145D0 (en) Composition
SG11202101920WA (en) Composition for eradicating helicobacter pylori
GB201804434D0 (en) Composition
IL289424A (en) Extended release gastro-retentive formulation against helicobacter pylori
GB201803923D0 (en) Compositions
PL3870195T3 (pl) Nowe probiotyki użyteczne w eradykacji zakażenia helicobacter pylori
GB201810024D0 (en) Composition
GB201809123D0 (en) Composition
GB201805676D0 (en) Compositions
GB201801425D0 (en) Compositions
GB201801596D0 (en) Composition
AU2018902387A0 (en) Helicobacter pylori immunotherapy
GB201914617D0 (en) Nutraceutical composition
PT3768284T (pt) Composições de flagelina entrecoccus para uso em terapia